IRIDEX CORP Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
IRIDEX CORP (IRIX) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of $381.00 thousand for the 12-month period ending 2019-12-28, per its 10-K filed 2020-03-13.
Discontinued › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2020-03-13
- IRIDEX CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2019-12-28 was $63.00K, a 25.88% decline year-over-year.
- IRIDEX CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2019-09-28 was $119.00K, a 2.59% increase year-over-year.
- IRIDEX CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2019-06-29 was $103.00K, a 9.57% increase year-over-year.
- IRIDEX CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2019-03-30 was $96.00K, a 4.35% increase year-over-year.
- IRIDEX CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2019 was $381.00K, a 1.55% decline from fiscal 2018.
- IRIDEX CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2018 was $387.00K, a 1.31% increase from fiscal 2017.
- IRIDEX CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2017 was $382.00K, a 5.91% decline from fiscal 2016.
- IRIDEX CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2016 was $406.00K, a 4.02% decline from fiscal 2016.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month |
|---|---|---|---|---|
| 2019-12-28 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $182.00K derived: sum of 2 quarters · filed 2020-03-13 | $285.00K derived: sum of 3 quarters · filed 2020-03-13 | $381.00K 10-K · filed 2020-03-13 |
| 2019-09-28 | $119.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $222.00K derived: sum of 2 quarters · filed 2019-11-08 | $318.00K 10-Q · filed 2019-11-08 | $403.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2019-06-29 | $103.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $199.00K 10-Q · filed 2019-08-07 | $284.00K derived: sum of 3 quarters · filed 2020-03-13 | $400.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2019-03-30 | $96.00K 10-Q · filed 2019-05-07 | $181.00K derived: sum of 2 quarters · filed 2020-03-13 | $297.00K derived: sum of 3 quarters · filed 2020-03-13 | $391.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-12-29 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $201.00K derived: sum of 2 quarters · filed 2020-03-13 | $295.00K derived: sum of 3 quarters · filed 2020-03-13 | $387.00K 10-K · filed 2020-03-13 |
| 2018-09-29 | $116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $210.00K derived: sum of 2 quarters · filed 2019-11-08 | $302.00K 10-Q · filed 2019-11-08 | $392.00K derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $186.00K 10-Q · filed 2019-08-07 | $276.00K derived: sum of 3 quarters · filed 2019-08-07 | $390.00K derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $92.00K 10-Q · filed 2019-05-07 | $182.00K derived: sum of 2 quarters · filed 2019-05-07 | $296.00K derived: sum of 3 quarters · filed 2019-05-07 | $390.00K derived: sum of 4 quarters · filed 2019-05-07 |
| 2017-12-30 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $204.00K derived: sum of 2 quarters · filed 2019-03-29 | $298.00K derived: sum of 3 quarters · filed 2019-03-29 | $382.00K 10-K · filed 2019-03-29 |
| 2017-09-30 | $114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $208.00K derived: sum of 2 quarters · filed 2018-11-06 | $292.00K 10-Q · filed 2018-11-06 | $385.00K derived: sum of 4 quarters · filed 2018-11-06 |
| 2017-07-01 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $178.00K 10-Q · filed 2018-08-08 | $271.00K derived: sum of 3 quarters · filed 2018-08-08 | $394.00K derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-04-01 | $84.00K 10-Q · filed 2018-05-08 | $177.00K derived: sum of 2 quarters · filed 2018-05-08 | $300.00K derived: sum of 3 quarters · filed 2018-05-08 | $394.00K derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $216.00K derived: sum of 2 quarters · filed 2018-03-14 | $310.00K derived: sum of 3 quarters · filed 2018-03-14 | $406.00K 10-K · filed 2018-03-14 |
| 2016-10-01 | $123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $217.00K derived: sum of 2 quarters · filed 2017-11-07 | $313.00K 10-Q · filed 2017-11-07 | $408.00K derived: sum of 4 quarters · filed 2017-11-07 |
| 2016-07-02 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $190.00K 10-Q · filed 2017-08-08 | $285.00K derived: sum of 3 quarters · filed 2017-08-08 | $377.00K derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-04-02 | $96.00K 10-Q · filed 2017-05-09 | $191.00K derived: sum of 2 quarters · filed 2017-05-09 | $283.00K derived: sum of 3 quarters · filed 2017-05-09 | $423.00K derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-01-02 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $187.00K derived: sum of 2 quarters · filed 2017-03-15 | $327.00K derived: sum of 3 quarters · filed 2017-03-15 | $423.00K 10-K · filed 2017-03-15 |
| 2015-10-03 | $92.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $232.00K derived: sum of 2 quarters · filed 2016-11-07 | $328.00K 10-Q · filed 2016-11-07 | $426.00K derived: sum of 4 quarters · filed 2016-11-07 |
| 2015-07-04 | $140.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $236.00K 10-Q · filed 2016-08-08 | $334.00K derived: sum of 3 quarters · filed 2016-08-08 | $431.00K derived: sum of 4 quarters · filed 2016-08-08 |
| 2015-04-04 | $96.00K 10-Q · filed 2016-05-09 | $194.00K derived: sum of 2 quarters · filed 2016-05-09 | $291.00K derived: sum of 3 quarters · filed 2016-05-09 | $461.00K derived: sum of 4 quarters · filed 2016-05-09 |
| 2015-01-03 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-31 | $195.00K derived: sum of 2 quarters · filed 2016-03-31 | $365.00K derived: sum of 3 quarters · filed 2016-03-31 | $459.00K 10-K · filed 2016-03-31 |
| 2014-09-27 | $97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $267.00K derived: sum of 2 quarters · filed 2015-11-10 | $361.00K 10-Q · filed 2015-11-10 | $457.00K derived: sum of 4 quarters · filed 2015-11-10 |
| 2014-06-28 | $170.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $264.00K 10-Q · filed 2015-08-10 | $360.00K derived: sum of 3 quarters · filed 2015-08-10 | $449.00K derived: sum of 4 quarters · filed 2015-08-10 |
| 2014-03-29 | $94.00K 10-Q · filed 2015-05-12 | $190.00K derived: sum of 2 quarters · filed 2015-05-12 | $279.00K derived: sum of 3 quarters · filed 2015-05-12 | $394.00K derived: sum of 4 quarters · filed 2015-05-12 |
| 2013-12-28 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-02 | $185.00K derived: sum of 2 quarters · filed 2015-04-02 | $300.00K derived: sum of 3 quarters · filed 2015-04-02 | $383.00K 10-K · filed 2015-04-02 |
| 2013-09-28 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | $204.00K derived: sum of 2 quarters · filed 2014-11-03 | $287.00K 10-Q · filed 2014-11-03 | -$282.00K derived: sum of 4 quarters · filed 2014-11-03 |
| 2013-06-29 | $115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $198.00K 10-Q · filed 2014-08-04 | -$371.00K derived: sum of 3 quarters · filed 2014-08-04 | -$292.00K derived: sum of 4 quarters · filed 2014-08-04 |
| 2013-03-30 | $83.00K 10-Q · filed 2014-05-05 | -$486.00K derived: sum of 2 quarters · filed 2014-05-05 | -$407.00K derived: sum of 3 quarters · filed 2014-05-05 | -$331.00K derived: sum of 4 quarters · filed 2014-05-05 |
| 2012-12-29 | -$569.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$490.00K derived: sum of 2 quarters · filed 2013-11-04 | -$414.00K derived: sum of 3 quarters · filed 2013-11-04 | -$328.00K 10-K · filed 2013-03-28 |
| 2012-09-29 | $79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $155.00K derived: sum of 2 quarters · filed 2013-11-04 | $241.00K 10-Q · filed 2013-11-04 | |
| 2012-06-30 | $76.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | $162.00K 10-Q · filed 2013-08-05 | ||
| 2012-03-31 | $86.00K 10-Q · filed 2013-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |